[{"AccountsPayableCurrent_0_Q3_USD":12708546.0,"ProceedsFromFeesReceived_3_Q3_USD":178170.0,"PrepaidInsurance_0_Q3_USD":542000.0,"PrepaidExpenseCurrentAndNoncurrent_0_Q3_USD":2715500.0,"PrepaidExpenseCurrent_0_Q3_USD":2715478.0,"PreferredStockValue_0_Q3_USD":null,"PreferredStockSharesOutstanding_0_Q3_shares":null,"PreferredStockSharesIssued_0_Q3_shares":null,"PreferredStockSharesAuthorized_0_Q3_shares":200000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PaymentsToAcquireInvestments_3_Q3_USD":82476539.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":23416036.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":136900.0,"OtherDepreciationAndAmortization_3_Q3_USD":1258.0,"OtherAssetsNoncurrent_0_Q3_USD":25000.0,"OtherAccruedLiabilitiesCurrentAndNoncurrent_0_Q3_USD":106600.0,"OperatingIncomeLoss_3_Q3_USD":-91520718.0,"OperatingIncomeLoss_1_Q3_USD":-42653635.0,"OperatingExpenses_3_Q3_USD":91520718.0,"OperatingExpenses_1_Q3_USD":42653635.0,"NonoperatingIncomeExpense_3_Q3_USD":147402.0,"NonoperatingIncomeExpense_1_Q3_USD":47444.0,"NoncashOrPartNoncashAcquisitionPayablesAssumed1_3_Q3_USD":null,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":54213231.0,"ProceedsFromSaleAndMaturityOfOtherInvestments_3_Q3_USD":119541235.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":569427.0,"ProceedsFromWarrantExercises_3_Q3_USD":2116969.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_3_Q3_USD":12500000.0,"UnrealizedGainLossOnInvestments_3_Q3_USD":-379699.0,"UnrealizedGainLossOnInvestments_1_Q3_USD":86745.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":52156.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":10241599000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":72687091.0,"StockholdersEquity_0_Q3_USD":72687091.0,"ShortTermInvestments_0_Q3_USD":76637802.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":40100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0_Q3_shares":3244248.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_3_Q3_shares":930000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_3_Q3_shares":356385.0,"ShareBasedCompensation_3_Q3_USD":22133630.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-270688619.0,"ResearchAndDevelopmentExpense_3_Q3_USD":65347708.0,"ResearchAndDevelopmentExpense_1_Q3_USD":33993974.0,"RepaymentsOfNotesPayable_3_Q3_USD":null,"RealizedInvestmentGainsLosses_3_Q3_USD":-513328.0,"RealizedInvestmentGainsLosses_1_Q3_USD":-336949.0,"PropertyPlantAndEquipmentOther_0_Q3_USD":null,"PropertyPlantAndEquipmentNet_0_Q3_USD":null,"PropertyPlantAndEquipmentGross_0_Q3_USD":16700.0,"ProfitLoss_3_Q3_USD":-91373316.0,"NetIncomeLoss_3_Q3_USD":-91373316.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":17478477.0,"NetIncomeLoss_1_Q3_USD":-42606191.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":37064696.0,"CommonStockValue_0_Q3_USD":17502.0,"CommonStockSharesOutstanding_0_Q3_shares":17501554.0,"CommonStockSharesIssued_0_Q3_shares":17501554.0,"CommonStockSharesAuthorized_0_Q3_shares":50000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":29276.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":8953897.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":11449294.0,"Cash_0_Q3_USD":11449294.0,"AssetsCurrent_0_Q3_USD":90887166.0,"ContractualObligation_0_Q3_USD":33000.0,"Assets_0_Q3_USD":90934441.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":32375200.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q3_USD":8013970.0,"AdditionalPaidInCapital_0_Q3_USD":343358208.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":16700.0,"AccruedVacationCurrent_0_Q3_USD":413500.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":174200.0,"AccruedLiabilitiesFairValueDisclosure_0_Q3_USD":0.0,"AccruedLiabilitiesCurrent_0_Q3_USD":5538804.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":5538800.0,"AccruedBonusesCurrentAndNoncurrent_0_Q3_USD":867000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":8288179.0,"ContractualObligationDueAfterFifthYear_0_Q3_USD":null,"ContractualObligationDueInNextTwelveMonths_0_Q3_USD":33000.0,"ContractualObligationDueInSecondYear_0_Q3_USD":null,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":26102432.0,"LiabilitiesCurrent_0_Q3_USD":18247350.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":90934441.0,"LeaseIncome_3_Q3_USD":8800.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_3_Q3_USD":10241599.0,"InterestPaidNet_3_Q3_USD":null,"InterestIncomeOther_3_Q3_USD":6100.0,"InterestIncomeExpenseNet_3_Q3_USD":1040429.0,"InterestIncomeExpenseNet_1_Q3_USD":297648.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":1812288.0,"IncreaseDecreaseInLeasingReceivables_3_Q3_USD":-58967.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":1281821.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":4362071.0,"IncomeTaxesPaidNet_3_Q3_USD":null,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-513328.0,"IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-42606191.0,"GrantsReceivableCurrent_0_Q3_USD":1609011.0,"GeneralAndAdministrativeExpense_3_Q3_USD":26173010.0,"GeneralAndAdministrativeExpense_1_Q3_USD":8659661.0,"EmployeeStockOwnershipPlanESOPCompensationExpense_3_Q3_USD":101100.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-5.36,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-2.44,"Depreciation_3_Q3_USD":1258.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-54213231.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":17038583.0,"Ticker":"RLMD","CIK":"1553643","name":"RELMADA THERAPEUTICS, INC.","OfficialName":"Relmada Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"772606380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211112"}]